A multicentre, prospective observation post-authorisation, open-label study of sublingual fentanyl tablets for relief of breakthrough pain in cancer patients and association with quality of life outcomes.
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Fentanyl (Primary)
- Indications Breast cancer; Cancer; Cancer pain; Gastrointestinal cancer; Head and neck cancer; Lung cancer; Neuropathic pain; Prostate cancer; Visceral pain
- Focus Therapeutic Use
- 31 Jul 2017 New trial record
- 25 Jul 2017 Results of subgroup (age more than or equal to 65 years and less than 65 years) analysis published in the Drugs in R and D
- 01 Dec 2015 Primary end point (Short Form 12 (version 2) [SF-12v2] Physical Component Summary (PCS) score) has been met as per the results published in the Clinical Drug Investigation.